Pharmalat is a pharmaceutical company founded in 1992, dedicated to the research and manufacture of high quality medicines, with distribution at national, Central American and Caribbean levels. It is considered one of the top ten pharmaceutical companies in Latin America, preferring consumers because of its high standards of quality, innovation and service.
Develop and commercialize cutting-edge pharmaceutical and food products to meet the health needs of our population.
To be a model of pharmaceutical company, to expand to new countries and markets implementing quality systems supported by the talent of our collaborators to contribute to improve the quality of life of the population.
Biomolecular Pharma Innovation
Biomolecular Pharma Innovation since its foundation in 2013, has been closely linked to the science, technology and innovation capacity of the human being. Through its existence, it has faced the challenge of growth with a spirit of struggle and perseverance, considering that the future offers innumerable possibilities by having a highly trained team and an image that is already a reality in the industry. At the beginning of its activities, the team dedicated its efforts to the development of the pharmaceutical specialties through which it would be launched to the market and made known to the Medical Corps. With the authorization of the Ministry of Public Health, the first products were launched into the pharmaceutical market under the strict supervision of the Quality Control Department.
In 2007, the Pharmaceuticals line Winzzer Medical Corporation, a strategy implemented by the executives of the Pharmalat Corporation, began with products such as Pantosek, Ceftriazzer, Dualdol and Gesimax, covering the national territory. To date they have 23 products in different presentations and with presence in the market of Guatemala and Nicaragua, expanding its presence in the market and obtaining the growth of its collaborators.
Pharmaceutical is a Guatemalan company dedicated to the distribution of generic pharmaceuticals for the care of human health, destined mainly to the institutional market, both public and private. Through rigorous procedures of elaboration and control of international standards of quality. We emphasize the obtaining of medicinal products of high quality.
Division eminently oriented to preventive health as nutrition; seeks to provide the medical community and consumers with the best products for their care. Pharma Natura’s vision is to achieve leadership in health care through state-of-the-art, state-of-the-art food products and services for the medical community.
CIM (Center for Medical Innovation)
The Medical Innovation Center (CIM) is made up of a group of medical specialists who provide services to patients with cancer and other chronic diseases, supporting and seeking effective solutions to improve the quality of life of each person, while working at innovation of clinics, products and services.
At Pharmalat we are committed to providing medicines and food by:
- The effectiveness and efficiency of the organization.
- Customer satisfaction.
- Compliance with the corresponding quality specifications, laws and regulations through the continuous improvement of our processes.
Estas prácticas comprenden normas reconocidas y respetadas internacionalmente, cuya opción y aplicación se recomienda a todos los países miembros. Las mismas sirven de base para el sistema de gestión de calidad de los productos farmacéuticos objeto del comercio internacional.
Dicha normativa, permite certificar a nivel nacional e internacional, que todas las unidades de negocio de Pharmalat, S.A., que distribuyen medicamentos, están autorizadas para: La producción, exportación, importación, venta y distribución de productos farmacéuticos. Las instalaciones industriales donde se fabrican los productos están sometidas a inspecciones regulares para comprobar si el fabricante se ajusta a las Buenas Prácticas de Manufactura e Inspección de la Calidad, según Informe 32.
Las instalaciones industriales donde se fabrican los productos están sometidas a inspecciones regulares para comprobar si el fabricante se ajusta a las Buenas Prácticas de Manufactura e Inspección de la Calidad, según Informe 32.
Pharmalat determines, provides and maintains infrastructure and equipment, relying on information technology to safeguard data capture, traceability and application of continuous improvement and thus provide a quality service to our customers.
Pharmalat ensures the design of the facilities, in order to avoid and reduce the risk of cross-contamination, which facilitates cleanliness and order in the work areas, thus enabling preventive maintenance on both equipment and the infrastructure.
In Pharmalat the maintenance of facilities and equipment is carried out by means of the procedures established for this work.